New IRB fee schedule is implemented
Along with the administrative transition of the Health Science Institutional Review Boards (IRBs) to the Office of the Vice Chancellor for Research and Graduate Education, a new IRB fee policy has been implemented effective Jan. 1, 2019. Because all campus IRBs will be supported by central campus funding, the OVCRGE has eliminated IRB fees in many circumstances.
The new fee policy applies to all UW–Madison faculty, staff, and students. Any studies already approved by a UW–Madison IRB will be transitioned to this new policy.
Highlights of the new fee policy include:
- Elimination of IRB review fees for research that is not industry sponsored, such as research sponsored by private foundations, investigator-initiated research that is unfunded or supported by internal UW–Madison funds, and research that only includes limited support from industry (e.g., providing a drug or device for a study, but little or no direct financial contributions)
- Maintenance of the current IRB fee schedule for industry sponsored studies reviewed by a UW–Madison IRB
- An increase in the compliance fee for fully industry sponsored studies ceded to independent IRBs (e.g., Western IRB, Quorum, Advarra)
Please also draw your attention to the National Institutes of Health (NIH) policy for the use of a single IRB for multi-site research, because it permits institutions to charge for direct costs associated with single IRB review (e.g., for the review of activities performed for personnel outside their institutions). At this time, the UW–Madison will not charge IRB fees under the NIH Single IRB Policy. However, some institutions are charging single IRB review fees, which must be accounted for in NIH grant budgets at the time that the grant application is submitted. For additional guidance regarding this NIH policy and its budget implications, please see Single IRB Guidance for UW Research Administrators.